Cargando…
Blood Eosinophils and Clinical Outcomes in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Propensity Score Matching Analysis of Real-World Data in China
Background and Objective: Elevated eosinophils in chronic obstructive pulmonary disease (COPD) are recognized as a biomarker to guide inhaled corticosteroids use, but the value of blood eosinophils in hospitalized exacerbations of COPD remains controversial. This study aimed to evaluate the accuracy...
Autores principales: | Cui, Yanan, Zhan, Zijie, Zeng, Zihang, Huang, Ke, Liang, Chen, Mao, Xihua, Zhang, Yaowen, Ren, Xiaoxia, Yang, Ting, Chen, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219875/ https://www.ncbi.nlm.nih.gov/pubmed/34179040 http://dx.doi.org/10.3389/fmed.2021.653777 |
Ejemplares similares
-
Methylxanthine Treatment in Patients Hospitalized for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in China: A Real-World Study Using Propensity Score Matching Analysis
por: Zhan, Zijie, et al.
Publicado: (2022) -
Real-world antibiotic use in treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in China: Evidence from the ACURE study
por: Ma, Yiming, et al.
Publicado: (2021) -
Clinical and economic burden of comorbid coronary artery disease in patients with acute exacerbation of chronic obstructive pulmonary disease: sex differences in a nationwide cohort study
por: Cui, Yanan, et al.
Publicado: (2022) -
Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study
por: Cui, Yanan, et al.
Publicado: (2021) -
Characteristics, Management and In-Hospital Clinical Outcomes Among Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in China: Results from the Phase I Data of ACURE Study
por: Liang, Chen, et al.
Publicado: (2021)